Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
22.83
-0.12 (-0.52%)
Jan 23, 2026, 3:00 PM CST
SHA:605177 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | -218.24 | -100.66 | 121.25 | 104.43 | 68.49 | 114.48 | Upgrade |
Depreciation & Amortization | 135.94 | 135.94 | 112.42 | 94.25 | 69.53 | 62.98 | Upgrade |
Other Amortization | 4.11 | 4.11 | 1.96 | 1.41 | 0.92 | 0.62 | Upgrade |
Loss (Gain) From Sale of Assets | 3.13 | 3.13 | 2.25 | 1.05 | 0.61 | -0.92 | Upgrade |
Asset Writedown & Restructuring Costs | 23.8 | 23.8 | 3.44 | 4.49 | 3.44 | 3.38 | Upgrade |
Loss (Gain) From Sale of Investments | -3.94 | -3.94 | -7.03 | -7.85 | -7.42 | - | Upgrade |
Provision & Write-off of Bad Debts | 0.86 | 0.86 | 2.72 | 1.31 | -1.01 | 0.85 | Upgrade |
Other Operating Activities | 119.49 | 132.46 | 11.38 | 0.2 | 7.18 | 3.3 | Upgrade |
Change in Accounts Receivable | -270.56 | -270.56 | -54.33 | -246.17 | -12.58 | -84.24 | Upgrade |
Change in Inventory | -240.69 | -240.69 | -148.97 | -63.04 | -158.47 | 19.82 | Upgrade |
Change in Accounts Payable | 139.16 | 139.16 | -138.81 | 45.44 | 2.71 | 31.19 | Upgrade |
Change in Other Net Operating Assets | 40.49 | 40.49 | 9.49 | -4.13 | 6.76 | -3.03 | Upgrade |
Operating Cash Flow | -287.1 | -156.55 | -84.06 | -70.35 | -23.6 | 146.9 | Upgrade |
Operating Cash Flow Growth | - | - | - | - | - | -32.19% | Upgrade |
Capital Expenditures | -123.39 | -211.61 | -227.47 | -87.82 | -121.97 | -61.08 | Upgrade |
Sale of Property, Plant & Equipment | 1.79 | 1.57 | 2.29 | 2.32 | 5.37 | 10.51 | Upgrade |
Investment in Securities | 123.38 | 96.18 | -110.08 | 20 | -220 | - | Upgrade |
Other Investing Activities | 7.8 | 23.7 | 0.7 | 1.52 | 2.4 | - | Upgrade |
Investing Cash Flow | 9.58 | -90.16 | -334.57 | -63.98 | -334.2 | -50.57 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 41.5 | Upgrade |
Long-Term Debt Issued | - | 204.4 | 172.5 | 27 | 2 | - | Upgrade |
Total Debt Issued | 321.68 | 204.4 | 172.5 | 27 | 2 | 41.5 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -51.5 | Upgrade |
Long-Term Debt Repaid | - | -224.79 | -220.09 | -6.38 | -12.54 | - | Upgrade |
Total Debt Repaid | -169.29 | -224.79 | -220.09 | -6.38 | -12.54 | -51.5 | Upgrade |
Net Debt Issued (Repaid) | 152.39 | -20.39 | -47.59 | 20.62 | -10.54 | -10 | Upgrade |
Issuance of Common Stock | 20.87 | 20.87 | 683.49 | - | - | 822.77 | Upgrade |
Repurchase of Common Stock | -25 | -25 | -30 | - | - | - | Upgrade |
Common Dividends Paid | -7.55 | -41.6 | -36.25 | -23.36 | -39.04 | -18.45 | Upgrade |
Other Financing Activities | 76.99 | 97.65 | 47.37 | 91.23 | -4.53 | -49.87 | Upgrade |
Financing Cash Flow | 217.7 | 31.54 | 617.02 | 88.48 | -54.12 | 744.46 | Upgrade |
Foreign Exchange Rate Adjustments | 1.85 | 2.54 | 0.99 | 0.22 | -0.29 | -0.32 | Upgrade |
Net Cash Flow | -57.98 | -212.63 | 199.38 | -45.63 | -412.21 | 840.47 | Upgrade |
Free Cash Flow | -410.49 | -368.16 | -311.53 | -158.17 | -145.57 | 85.82 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | -45.97% | Upgrade |
Free Cash Flow Margin | -49.36% | -30.73% | -22.97% | -13.41% | -20.44% | 9.73% | Upgrade |
Free Cash Flow Per Share | -3.62 | -3.29 | -2.49 | -1.39 | -1.27 | 0.98 | Upgrade |
Cash Interest Paid | - | - | - | 1.51 | - | - | Upgrade |
Cash Income Tax Paid | - | -3.13 | 19.37 | -12.47 | -7.63 | 41.9 | Upgrade |
Levered Free Cash Flow | 164.61 | -20.89 | -143.19 | -6.44 | -57.01 | 164.77 | Upgrade |
Unlevered Free Cash Flow | 170.71 | -19.62 | -140.94 | -5.91 | -56.87 | 165.19 | Upgrade |
Change in Working Capital | -352.25 | -352.25 | -332.45 | -269.64 | -165.34 | -37.78 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.